3 High-Risk Biotechs That Could Pop or Drop in 2018 Post author:Sam Post published:February 4, 2018 Post category:BioPharma A look at three biotech companies that face make-or-break catalysts this year. Source: BioSpace You Might Also Like Certara Corporation Releases New Version Of D360, Its Industry-Leading Informatics Platform For Pharma Discovery Scientists January 30, 2017 Cambridge's Dimension Therapeutics Tanks to a New Low After Revealing Interim Hemophilia B Data January 31, 2017 Investment Group Just Paid $605 Million for This Bay Area Pharma June 7, 2017
Certara Corporation Releases New Version Of D360, Its Industry-Leading Informatics Platform For Pharma Discovery Scientists January 30, 2017
Cambridge's Dimension Therapeutics Tanks to a New Low After Revealing Interim Hemophilia B Data January 31, 2017
